A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial - Eriksson, B I; Dahl, O E; Büller, H R (J Thromb Haemost, 2005)
, et al. BISTRO II Study Group.